Zacks Investment Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$131M Buy
1,085,250
+4,128
+0.4% +$477K 1.05% 21
2025
Q4
$114M Buy
1,081,122
+52,402
+5% +$4.92M 0.89% 24
2025
Q3
$86.3M Buy
1,028,720
+15,557
+2% +$1.28M 0.69% 39
2025
Q2
$80.2M Sell
1,013,163
-1,149
-0.1% -$91.3K 0.69% 40
2025
Q1
$91M Buy
1,014,312
+39,854
+4% +$3.72M 0.85% 31
2024
Q4
$96.9M Sell
974,458
-217,260
-18% -$22.4M 0.9% 27
2024
Q3
$135M Buy
1,191,718
+115,880
+11% +$13.8M 1.17% 22
2024
Q2
$133M Buy
1,075,838
+165,587
+18% +$21.3M 1.5% 14
2024
Q1
$120M Buy
910,251
+97,718
+12% +$12M 1.28% 17
2023
Q4
$88.6M Sell
812,533
-51,593
-6% -$5.36M 1.09% 24
2023
Q3
$89M Sell
864,126
-306,414
-26% -$33M 1.15% 21
2023
Q2
$135M Buy
1,170,540
+29,274
+3% +$3.32M 1.7% 11
2023
Q1
$121M Buy
1,141,266
+27,806
+2% +$3M 1.63% 11
2022
Q4
$124M Buy
1,113,460
+49,763
+5% +$5.09M 1.72% 11
2022
Q3
$91.6M Buy
1,063,697
+28,056
+3% +$2.5M 1.46% 13
2022
Q2
$94.4M Buy
1,035,641
+62,538
+6% +$5.54M 1.44% 15
2022
Q1
$79.8M Buy
973,103
+63,445
+7% +$5M 1.11% 26
2021
Q4
$69.7M Buy
909,658
+259,858
+40% +$20.7M 0.98% 26
2021
Q3
$48.8M Sell
649,800
-182,807
-22% -$13.9M 0.77% 42
2021
Q2
$64.8M Sell
832,607
-107,981
-11% -$8.03M 1.05% 23
2021
Q1
$69.2M Buy
940,588
+8,262
+0.9% +$609K 1.23% 18
2020
Q4
$72.8M Sell
932,326
-150,958
-14% -$11.5M 1.34% 13
2020
Q3
$85.7M Buy
1,083,284
+4,415
+0.4% +$346K 1.74% 9
2020
Q2
$79.6M Buy
1,078,869
+36,885
+4% +$2.78M 1.75% 11
2020
Q1
$76.5M Sell
1,041,984
-452
-0% -$35.5K 1.88% 9
2019
Q4
$90.5M Buy
1,042,436
+18,399
+2% +$1.51M 1.69% 9
2019
Q3
$82.3M Buy
1,024,037
+19,965
+2% +$1.6M 1.65% 10
2019
Q2
$80.3M Sell
1,004,072
-29,967
-3% -$2.29M 1.65% 11
2019
Q1
$79M Sell
1,034,039
-339,453
-25% -$25.4M 1.69% 10
2018
Q4
$100M Sell
1,373,492
-106,111
-7% -$7.49M 2.42% 2
2018
Q3
$100M Buy
1,479,603
+40,951
+3% +$2.61M 2.09% 4
2018
Q2
$83.3M Buy
1,438,652
+23,753
+2% +$1.34M 1.81% 5
2018
Q1
$73.5M Buy
1,414,899
+12,275
+0.9% +$663K 1.63% 7
2017
Q4
$75.3M Buy
1,402,624
+938
+0.1% +$52K 1.64% 7
2017
Q3
$85.6M Buy
1,401,686
+10,836
+0.8% +$657K 2.01% 4
2017
Q2
$85.1M Buy
1,390,850
+69,751
+5% +$4.25M 2.11% 4
2017
Q1
$80.1M Buy
1,321,099
+128,788
+11% +$7.81M 2.04% 4
2016
Q4
$67M Sell
1,192,311
-63,402
-5% -$3.71M 1.92% 4
2016
Q3
$74.8M Buy
1,255,713
+327,650
+35% +$19.2M 2.12% 2
2016
Q2
$51M Buy
928,063
+28,041
+3% +$1.49M 1.56% 12
2016
Q1
$45.4M Buy
900,022
+54,163
+6% +$2.65M 1.44% 14
2015
Q4
$42.6M Sell
845,859
-35,676
-4% -$1.8M 1.39% 12
2015
Q3
$41.5M Sell
881,535
-20,097
-2% -$1.07M 1.45% 9
2015
Q2
$49M Sell
901,632
-12,087
-1% -$678K 1.55% 7
2015
Q1
$50.1M Buy
913,719
+42,408
+5% +$2.4M 1.59% 6
2014
Q4
$47.2M Buy
871,311
+47,855
+6% +$2.67M 1.53% 6
2014
Q3
$46.5M Buy
823,456
+55,179
+7% +$3.1M 1.62% 8
2014
Q2
$42.4M Buy
768,277
+38,445
+5% +$2.1M 1.51% 9
2014
Q1
$39.5M Buy
729,832
+57,511
+9% +$2.98M 1.46% 10
2013
Q4
$32.1M Buy
672,321
+151,255
+29% +$6.91M 1.27% 11
2013
Q3
$23.7M Buy
521,066
+33,083
+7% +$1.51M 1.02% 20
2013
Q2
$21.6M Buy
+487,983
New +$21.8M 0.99% 19

Other funds holding MRK

Zacks Investment Management's MRK Position: Q1 2026 in Review

Zacks Investment Management increased its Merck (MRK) stake by 0.38% in Q1 2026, buying an estimated $477K and bringing the position to 1,085,250 shares worth $131M. The position accounts for 1.05% of the portfolio, ranked #21.

Zacks Investment Management first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $135M in Q3 2024. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Zacks Investment Management held 1,085,250 shares of Merck worth $131M as of Q1 2026.
  • Zacks Investment Management bought 4,128 Merck shares in Q1 2026, an estimated $477K.
  • Merck made up 1.05% of Zacks Investment Management's portfolio in Q1 2026, its #21 holding.
  • Zacks Investment Management first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • Zacks Investment Management's Merck position peaked at $135M in Q3 2024.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Zacks Investment Management's 13F filing for Q1 2026, filed 14 May 2026.